# The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow

> **NCT01468285** · PHASE4 · COMPLETED · sponsor: **Abbott Products** · enrollment: 27 (actual)

## Conditions studied

- Gait or Balance Disorder Problems

## Interventions

- **DRUG:** betahistine dihydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01468285
- **Lead sponsor:** Abbott Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468285, "The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01468285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*